Phase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerations.

por Newell, D. R.
Publicado 1990

Flasks, fibres and flanks – pre-clinical tumour models for predicting clinical antitumour activity

por Newell, D R
Publicado 2001

Getting the right dose in cancer chemotherapy – time to stop using surface area?

por Newell, D R
Publicado 2002

Lifestyle and health behaviour change support in traditional acupuncture: a mixed method survey study of reported practice (UK)

por Pinto, J., Bradbury, K., Newell, D., Bishop, F. L.
Publicado 2022

Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK

por Newell, D R, Searle, K M, Westwood, N B, Burtles, S S
Publicado 2003

Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport

por Smith, P G, Marshman, E, Newell, D R, Curtin, N J
Publicado 2000

Pharmacokinetic studies in mice with ICI D0490, a novel recombinant ricin A-chain immunotoxin.

por Calvete, J. A., Newell, D. R., Charlton, C. J., Wright, A. F.
Publicado 1993

Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.

por Muindi, J. R., Newell, D. R., Smith, I. E., Harrap, K. R.
Publicado 1983

A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.

por Lowis, S. P., Price, L., Pearson, A. D., Newell, D. R., Cole, M.
Publicado 1998

Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro

por Bowman, K J, Newell, D R, Calvert, A H, Curtin, N J
Publicado 2001

Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics

por Newell, D R, Burtles, S S, Fox, B W, Jodrell, D I, Connors, T A
Publicado 1999

The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition

por Haagensen, E J, Kyle, S, Beale, G S, Maxwell, R J, Newell, D R
Publicado 2012

PHL4/411: Getting Practice on the Internet

por G. Neville, R, W. Ricketts, I, McCowan, C, Hoskins, G, Fenton, I, Newell, D
Publicado 1999

Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusion.

por Foster, B. J., Newell, D. R., Gumbrell, L. A., Jenns, K. E., Calvert, A. H.
Publicado 1993

Pharmacokinetic studies with the antifolate C2-desamino-C2-methyl-N10-propargyl-2'-trifluoromethyl-5,8-dideazafolic acid (CB3988) in mice and rats using in vivo 19F-NMR spectroscop...

por Newell, D. R., Maxwell, R. J., Bisset, G. M., Jodrell, D. I., Griffiths, J. R.
Publicado 1990

Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue

por Monks, N R, Blakey, D C, Curtin, N J, East, S J, Heuze, A, Newell, D R
Publicado 2001

Invited Article: A precise instrument to determine the Planck constant, and the future kilogram

por Haddad, D., Seifert, F., Chao, L. S., Li, S., Newell, D. B., Pratt, J. R., Williams, C., Schlamminger, S.
Publicado 2016

Bridging classical and quantum mechanics

por Haddad, D, Seifert, F, Chao, L S, Li, S, Newell, D B, Pratt, J R, Williams, C, Schlamminger, S
Publicado 2016

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.

por English, M. W., Lowis, S. P., Peng, B., Boddy, A., Newell, D. R., Price, L., Pearson, A. D.
Publicado 1996